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Abstract
Background: Sciatica is common and associated with significant impacts for the individual and society. The SCOPiC
randomised controlled trial (RCT) (trial registration: ISRCTN75449581) tested stratified primary care for sciatica by
subgrouping patients into one of three groups based on prognostic and clinical indicators. Patients in one group
were ‘fast-tracked’ for a magnetic resonance imaging (MRI) scan and spinal specialist opinion. This paper reports
qualitative research exploring patients’ and clinicians’ perspectives on the acceptability of this ‘fast-track’ pathway.
Methods: Semi-structured interviews were conducted with 20 patients and 20 clinicians (general practitioners,
spinal specialist physiotherapists, spinal surgeons). Data were analysed thematically and findings explored using
Normalisation Process Theory (NPT) and ‘boundary objects’ concept.
Results: Whilst the ‘fast-track’ pathway achieved a degree of ‘coherence’ (i.e. made sense) to both patients and
clinicians, particularly in relation to providing early reassurance based on MRI scan findings, it was less ‘meaningful’
to some clinicians for managing patients with acute symptoms, reflecting a reluctance to move away from the
usual ‘stepped care’ approach. Both groups felt a key limitation of the pathway was that it did not shorten patient
waiting times between their spinal specialist consultation and further treatments.
Conclusion: Findings contribute new knowledge about patients’ and clinicians’ perspectives on the role of imaging
and spinal specialist opinion in the management of sciatica, and provide important insights for understanding the
‘fast-track’ pathway, as part of the stratified care model tested in the RCT.
Future research into the early referral of patients with sciatica for investigation and specialist opinion should include
strategies to support clinician behaviour change; as well as take into account the role of imaging in providing
reassurance to patients with severe symptoms in cases where imaging reveals a clear explanation for the patient’s
pain, and where this is accompanied by a thorough explanation from a trusted clinical expert.
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Background
Sciatica is a common form of low back pain (LBP)
characterised by pain radiating into the leg [1]. Unlike
LBP alone, sciatica often has a clear ‘biomedical’ cause,
most commonly a disc prolapse compressing or irritat-
ing a spinal nerve root [2]. Sciatica is often experienced
as acute symptoms resolving over several weeks or
months, either naturally or with treatment; however, up
to 30% of people will still experience pain after a year
[1]. When compared to LBP alone, patients with sciatica
have worse pain and disability, poorer quality of life and
use more healthcare resources [3, 4].
Current usual clinical management for most patients
with sciatica follows a ‘stepped’ care approach, with
initial conservative management in primary care com-
prising low-intensity treatments (e.g. advice and educa-
tion, ‘wait-and-see’ approaches, pain medications),
before moving to more intensive treatments (e.g. courses
of physiotherapy) if symptoms persist. Patients whose
symptoms still fail to improve are referred to specialist
spinal services for investigations and consideration for
more invasive treatments such as spinal injections and
surgery.
An alternative to stepped care is a stratified care ap-
proach, whereby subgroups of patients are matched to
appropriate treatments early on. Stratified care aims to
‘identify those who will have the most clinical benefit or
least harm from a specific treatment’ in order to ‘make
the best decisions for groups of similar patients’ [5]. In
non-specific LBP, a model of stratified care based on
prognostic risk of persistent disabling back pain, using a
brief self-report tool – the STarT Back tool [6] and
matched treatments, has been shown to be superior to
non-stratified care both in terms of clinical outcomes
and cost-effectiveness [7, 8].
Building on this evidence, the SCOPiC (SCiatica Out-
comes in Primary Care) randomised controlled trial
(RCT) (Trial registration: ISRCTN75449581), tested the
clinical and cost-effectiveness of a new model of strati-
fied care for UK National Health Service (NHS) sciatica
patients consulting in primary care, compared with
usual, non-stratified care. Eligible patients randomised to
the intervention arm were stratified into one of three
groups based on a combination of prognostic and
clinical information [9]. Each of the groups was matched
to a care pathway. Patients in group 1 received brief self-
management support (up to 2 sessions with a physio-
therapist). Those in group 2 received a course of up to 6
sessions of physiotherapist-led care. Patients in group 3
were ‘fast-tracked’ for a Magnetic Resonance Imagining
scan (MRI) and spinal specialist consultation within 4
weeks, for consideration of their suitability for other
more invasive treatments, such as spinal injections or
surgery. After that point, patient care and any onward
treatments such as injections or surgery followed routine
NHS practice and waiting times. The trial showed that
this stratified care model was not superior to usual, non-
stratified care for the primary outcome: time to first
symptom resolution [10]. The majority of participants in
both of the arms of the trial reported resolution over the
12months of the trial.
This paper reports on the findings from nested quali-
tative research that aimed to understand the acceptabil-
ity of the ‘fast-track’ pathway to patients and clinicians,
i.e. general practitioners (GPs), spinal specialist physio-
therapists and spinal surgeons. The reason for focusing
on this aspect of the trial specifically is the novelty of
the ‘fast-track’ pathway to MRI and spinal specialist
opinion. The development of the ‘fast-track’ pathway
was based on evidence of variation in clinical practice in
the UK NHS in terms of referrals from general practice
to specialist spinal services, resulting in delays in some
patients with severe pain being referred to specialist ser-
vices, and subsequently delays in these patients receiving
appropriate treatments [11]. As a result, the UK Spinal
Taskforce [11] identified the need for evidence on the
clinical and cost effectiveness of early referral of patients
with severe symptoms for consideration of treatments
such as surgery or spinal epidural injections, to assess
whether ‘fast-tracking’ a group of patients can lead to
improvement in these patients’ outcomes. See [10] full
details of the trial procedures.
However, clinicians’ and patients’ views towards the
acceptability of ‘fast-tracking’ patients with severe sciat-
ica symptoms for early investigation and spinal specialist
opinion, and how this is experienced in practice, is
unknown. This is important, as exploring how a care
pathway is perceived and experienced by patients and
clinicians in everyday practice can provide important
context for interpreting outcomes in pragmatic RCTs
[12, 13]. The findings presented in this paper provide
useful insights for understanding this element of the
stratified care model that was tested, and whilst, based
on the RCT findings there is no strong justification to
implement this model of stratified care, other models of
stratification could be developed and would require
testing. The insights from the qualitative findings can
therefore have potential implications for future interven-
tion design, as well as future clinical management of
patients with sciatica.
Theoretical frameworks
In the absence of suspected serious pathology, the ‘fast-
track’ care pathway clearly represented a change to usual
care management for a subgroup of patients with
sciatica. Changing healthcare practice holds diverse
challenges [14] depending on whether an intervention is
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considered meaningful and relevant to clinicians and
patients, and the degree to which the intervention is
seen to ‘fit’ within established ways of working [15].
Examining such issues using a theoretically-underpinned
approach can extend the scope of purely descriptive
approaches, enabling a more cogent and coherent ex-
planation of the issues identified in the data. As such, we
drew on two theoretical frameworks to guide the
inquiry. The first was Normalisation Process Theory
(NPT) [16], a theoretical framework that has been widely
used to explore the introduction of new healthcare inter-
ventions across a diverse range of settings, e.g. low back
pain [17]; cancer care [18]; and mental health [19]. NPT
provides a framework for understanding why some
healthcare interventions are accepted and more success-
fully embedded in routine practice than others [20]. It
aims to identify and explain ‘factors that promote and
inhibit the routine incorporation of complex interven-
tions into everyday practice’ [20], through highlighting
the ‘ways in which work must be reconfigured both indi-
vidually and collectively by multiple stakeholders
involved in the work of implementation’ [21], thus tak-
ing into account both the individual level and broader
system and organisation level factors. This aim is
reflected in the framework’s four main components, as
outlined in Murray et al. [20]: coherence (or sense-
making); cognitive participation (or engagement); col-
lective action (work done to enable the intervention to
happen); and reflexive monitoring (formal and informal
appraisal of the benefits and costs of the intervention).
We drew on the concept of ‘coherence’ in particular as a
lens through which to interpret our interview findings.
Coherence relates to the degree to which a new inter-
vention is seen to be ‘meaningful’ to key stakeholders,
and whether it ‘makes sense’ within the context of exist-
ing ways of working. Whether clinicians and patients
‘buy in’ to a new approach is key to its early adoption
and implementation. The concept of coherence thus
aligns closely with our aims, as the degree to which clini-
cians and patients perceive the ‘fast-track’ pathway as
making sense in the context of the existing care pathway
for sciatica is key in understanding its overall
acceptability.
The second theoretical framework used was Allen’s
[22] conceptualisation of care pathways as ‘boundary
objects’. Allen defines a ‘boundary object’ as a loose
concept, but with strong cohesive power, which enables
the bringing together of the interests of different groups,
whilst still allowing these groups to maintain their
respective social identities. Allen argues that care path-
ways can be considered as ‘boundary objects’ in that they
have the ability to ‘align clinical, management and
service user interests around a healthcare quality
agenda.’ [22:355]. She also points out, however, that they
can at the same time give rise to conflicting agendas
among different stakeholders (e.g. clinicians, patients,
managers) which results in challenges when trying to
meet the needs of those groups. This ‘boundary object’
conceptualisation was also drawn-upon as a lens through
which to interpret our findings, enabling the investiga-
tion of how the ‘fast-track’ pathway addressed the shared
goals of patients and the three clinician groups (GPs,
spinal specialist physiotherapists and spinal surgeons),
aspects in which the ‘fast-track’ pathway did not align
with the priorities of these respective groups, and where
competing agendas were present in terms of its goals,
components and operationalisation.
Methods
One-to-one semi-structured interviews were conducted
with patients on the ‘fast-track’ pathway in the stratified
care arm of the SCOPiC trial (n = 20), and clinicians
(n = 20; 7 spinal physiotherapists; 9 GPs; 4 spinal
surgeons) between January 2016 and February 2018. In-
terviews were carried out by the lead author, BS (male,
PhD), a social science researcher with significant qualita-
tive research experience. The three clinician groups had
differing levels of involvement in the trial (the published
trial protocol paper provides full details [23]). GPs
identified patients with suspected sciatica for invitation
to the SCOPiC research clinics for assessment of their
eligibility to participate in the trial. Spinal specialist
physiotherapists were directly involved in providing
spinal specialist opinion as part of the ‘fast-track’
pathway in NHS spinal interface clinics – these are
multi-professional services at the interface between
primary and secondary care in the NHS. Spinal surgeons
were not involved in assessing patients as part of the
‘fast-track’ pathway following their MRI scan. Some
patients were referred from the interface clinics for a
consultation with a surgeon, however the surgeons
would not necessarily be aware that a patient was
participating in the trial.
The study settings were general practices, NHS based
spinal clinics and secondary care NHS Trusts in the
Midlands of England, North West England and Wales,
UK. The study received ethical approval from the NRES
Committee West Midlands – Solihull, 17/03/2015, ref.:
15/WM/0078.
Recruitment
Patients were recruited by invitation letter and then via
phone, having consented to contact as part of their par-
ticipation in the RCT. Patients were purposively sampled
to capture diverse characteristics including treatment
centre attended, and participant demographics: age,
gender, leg pain intensity, treatments received (including
patients who had received invasive treatments such as
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spinal injections or surgery) and response to treatment.
Clinicians were initially approached via email (in the
case of some GPs via their practice manager), followed
by a telephone call or email. Clinicians were sampled for
variation in geographical location across the areas in-
volved in the trial (Staffordshire, North Shropshire,
Cheshire, and Wales). GPs were further purposively
sampled based on the number of patients during the
trial for whom a sciatica related Read code (i.e. symp-
tom/diagnostic code) had been entered, prompting a
study specific electronic ‘pop-up’ on the GP’s computer
system indicating that the patient may be eligible for
invitation to the SCOPiC clinics. It was felt that
interviewing those GPs who had had most opportunity
to engage with the trial in terms of identifying patients
to be invited to the SCOPiC research clinics, might yield
rich interview data. Sampling based on level of engage-
ment was not relevant for the other clinician groups; the
spinal physiotherapists had, by definition, been involved
in the management of this group of patients in terms of
providing spinal specialist consultations as part of the
‘fast-track’ pathway; spinal surgeons would not have
been aware of which patients they had seen that were
part of the ‘fast-track’ pathway (see [23] for a full details
of the trial procedures). Out of 32 patients invited to
interview, 12 patients declined to take part, citing lack of
time to participate. No clinicians declined to participate,
and no patients or clinicians withdrew once having
agreed to be interviewed.
Data collection
Interviews with patients, spinal physiotherapists and
spinal surgeons were conducted after the 4-month
follow-up point in the RCT. This was to allow patients
to reflect upon their experiences of the ‘fast-track’ path-
way up to that point, and for clinicians to have had the
opportunity to see patients as part of the ‘fast-track’
pathway. Interviews with GPs were conducted once
recruitment to the trial had finished (November 2017
onwards) to avoid the possibility of influencing their
normal referral patterns of patients with sciatica. Of the
20 patient interviews, 13 took place at participants’
homes; two at the University; and five via telephone, in
line with participants’ preferences. Interviews lasted
between 21min and 1 h 15min (average: 48 min). Of the
20 clinician interviews, eight were carried out at the
clinician’s practice or hospital; four at the University and
eight via telephone. Clinician interviews lasted between
19min and 32 min (average: 26 min).
Interviews were audio-recorded, with the exception of
one GP interview in which the GP consented to take
part in an interview but not to being audio-recorded.
Instead, the interviewer took detailed notes during and
immediately after the interview to capture that GP’s
views. All participants were given an information letter
explaining the study prior to providing written informed
consent at the start of interviews, or audio-recorded
consent in the case of telephone interviews. Consent was
reaffirmed verbally at the end of each interview.
Separate topic guides were used for patient and
clinician interviews, covering a range of areas relevant to
the qualitative study aims (see Appendix). However, the
interviewer still retained flexibility to follow up on any
unexpected findings emerging during the interview.
Early findings informed subsequent interviews, with the
topic guides iteratively revised throughout the data-
collection process. Field notes were not made during in-
terviews as it was felt this could negatively impact upon
the rapport between interviewer and interviewee.
Analysis
Audio-recordings of interviews were transcribed and
anonymised. A two stage analysis framework was
adopted incorporating an inductive thematic analysis
[24] followed by mapping the identified themes onto the
two theoretical frameworks: the ‘coherence’ construct
within NPT and the conceptualisation of care pathways
as ‘boundary objects’. Analysis was an iterative process
and data collection continued until saturation was
judged to have been reached, defined as ‘informational
redundancy’– the point at which additional data no
longer offers new insights [25].
Anonymised transcripts were first systematically coded
on a line-by-line basis by one of the authors (BS) with
the aid of the software program Nvivo 10, in order to
identify recurrent concepts inductively. Coding was at
first largely descriptive, and later became more concep-
tual as interpretations of the data moved towards a
higher level of theoretical abstraction. Coding was reflex-
ive and recursive, with codes being revisited in light of
the findings of subsequent data-collection. A random
sample of 6 patient transcripts and 6 clinician transcripts
was independently coded by three other members of the
team. Coders brought different disciplinary perspectives
to the data (BS medical sociology; BB social science; MA
clinical academic general practice; KK clinical academic
physiotherapy and spinal specialist expertise). The aim
was to understand cross-disciplinary perspectives on the
data and, through discussion, to come to an agreement
on shared meanings and interpretations.
Member-checking – in terms of sending transcripts
and findings to participants for comment and feedback
─ was not employed. This was principally due to the
across-case, rather than within-case, focus of the ana-
lysis, which meant it would have been difficult for partic-
ipants to comment on the validity of the interpretations
of their own data when included within an analysis of
the broader dataset. Whilst we chose not to seek
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participants’ feedback on the across-case findings, we do
acknowledge this could have offered some additional in-
sights on the findings. Instead, participants were given
the opportunity to receive a copy of the findings upon
completion of the analysis. Patient perspectives were in-
cluded in the data analysis, however, as early findings
from the patient interview data, along with a sample of
three interview transcripts, were shared with four
patients from the SCOPiC trial’s Patient and Public In-
volvement and Engagement (PPIE) group. A meeting
was held in which the researchers looked through these
transcripts with the PPIE members and explored
whether their interpretations of the data aligned with
the emergent findings. All four PPIE members were
broadly in agreement with the early interpretations of
the interview data. Following full analysis, findings were
again presented to the same PPIE group. All four PPIE
members expressed agreement with the final interpreta-
tions of the data and finalised themes. The researchers
also discussed with PPIE members the implications of
the findings, gaining their views on how findings might
inform future research and clinical practice. The impli-
cations of the findings will be outlined later in the Dis-
cussion and Conclusion sections.
Data were analysed thematically using the constant
comparison method [26], looking for connections
within and across interviews, and across codes,
highlighting data consistencies and variations. Whilst
patient and clinician data were initially coded separ-
ately, they were then mapped onto one another,
looking at how each of the main themes identified
did or did not manifest across both the clinician and
patient interviews. The second stage of the analysis
involved mapping the themes identified in both the
patients’ and clinicians’ interviews onto the ‘coher-
ence’ construct of NPT and the conceptualisation of
care pathways as ‘boundary objects’. We explored
the degree to which the identified themes could be
seen to ‘fit’ within these frameworks, and how the
theoretical constructs manifested in relation to these
themes. In what follows we outline the characteris-
tics of the participant sample, before reporting the
key themes.
Results
Patient participant characteristics
Ten patient participants were female and 10 male, aged
from 28 to 86 years (average age: 52), and represented a
range of occupation types. Leg pain intensity measured
at the 4-month follow-up point in the RCT varied widely
between 1/10 and 10/10, with an average of 5.3/10.
Symptom duration for the current episode of sciatica
ranged from symptoms having resolved by 3 months, to
symptoms still experienced at 11–16months (average:
5–6 month symptom duration). Table 1, below, summa-
rises the characteristics of the 20 patients interviewed:
Information was available from clinical report forms
about the care patients received following their spinal
specialist consultation for all 20 participants. Additional
medical record data about care was then retrieved after
the 12months of the total RCT follow-up, and these
data were available for 17 of the 20 participants. Since
patient interviews were conducted after the 4-month
RCT follow-up point, some medical record data postdate
the interviews. Figure 1, below, displays information on
investigations, referrals and treatments received by the
patients participating in the interviews, along with
average waiting times for receipt of treatments from the
time of referral. Additionally, whilst 4 patients reported
in interviews that they had either undergone or were
awaiting spinal surgery, this information was not
available in the medical record data.
Clinician participant characteristics
Eleven clinicians were female and nine male. Of these, 5
GPs were female and 4 male, 6 spinal physiotherapists
were female and 1 male, and all 4 spinal surgeons were
male. The length of time clinicians had been practising
ranged from 9 to 31 years. GPs were reasonably equally
spread across the geographical regions involved in the
trial.
Principal findings
Three main themes were identified in both the patient
and clinician datasets; however, in relation to the patient
interviews one theme was not identified in the clinician
data: ‘impact on life and sense of identity’. Though
clinicians expressed an awareness of the impact of
sciatica on patients’ lives, they discussed this issue
mainly in relation to how it informed their clinical
management. Whilst the other three themes relate
directly to the experiences and perceptions of the ‘fast-
track’ pathway, this theme as it emerged in the patient
data is broader in scope and focused primarily on expe-
riences outside of the healthcare setting. For this reason,
this theme has been reported elsewhere [27]. The three
key themes identified in relation to both the patient and
clinician data were:
1) Acceptability of the ‘fast-track’ care pathway
2) Perceived benefits of the ‘fast-track’ care pathway
3) Waiting times for onward treatment following
being ‘fast-tracked’
A summary of the findings in relation to each of these
key themes is presented in Table 2, below:
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Acceptability of the ‘fast-track’ care pathway
All patients reported being pleased and surprised by the
speed of receiving an MRI scan (which was on average
5 days following randomisation in the RCT) and subse-
quent spinal specialist appointment at an interface clinic
(average: 11.5 days following randomisation). Patients
drew contrast between this and their previous experi-
ences of long NHS waiting times for investigations and
treatments:
Extract 1
Patient ID 4: I went for my scan more or less straight
after [the SCOPiC clinic appointment]. I even
commented how quick it was, because normally you
wait and wait and wait, don’t you? I was shocked
and pleased because … It seemed like I’d jumped the
queue! (Female, aged 49)
Clinicians reported finding it acceptable for patients
identified as needing spinal specialist assessment and
consideration for more invasive treatments to be seen by
those specialists sooner than is usually the case in
current practice. In particular, clinicians expressed
positive views that for those patients who were suitable
for invasive treatments, ‘fast-tracking’ them through the
initial phase of the care pathway and onto NHS waiting
lists sooner reduced the overall time period it took for
them to receive these treatments, enabling the patient’s
pain to resolve more quickly and allowing them to get
back to work and usual activities sooner:
Extract 2
Spinal physiotherapist 2: There was a patient I
saw six or seven weeks down the line, and they
were struggling. They were quite severe and their
Table 1 Summary of Patient Participant Characteristics: Provides a summary of the characteristics of the 20 patients interviewed
Patient
ID
Age Gender Self-reported occupation
type
Duration of current symptoms in months at time of interview (4-
month follow-up)
Leg pain
intensity
over
past 2
weeks
(at 4-
month
follow-
up)
Self-reported
symptoms at 4-
month follow-
up compared to
baseline
*For five patients, symptoms had resolved prior to being
interviewed, as indicated below
1 62 F Unemployed due to
sciatica
5–6 9/10 Worse
2 36 F Radiographer Symptoms resolved prior to interview, following 3 month duration 0/10 Completely
recovered
3 53 M Compliance director 7–10 4/10 Better
4 49 F Pottery worker 7–10 7/10 Same
5 44 M Assistant manager 9–12 7/10 Same
6 60 F Dining hall assistant Symptoms resolved prior to interview, following 3 month duration 3/10 Better
7 64 M Retired 7–10 9/10 Much worse
8 42 M Builder 9–12 10/10 Much worse
9 44 F Early years practitioner 7–10 7/10 Same
10 57 M Pottery worker 5–6 4/10 Better
11 66 M Ambulance driver 6–8 3/10 Better
12 86 F Retired Symptoms resolved prior to interview, following 4 months’
duration
2/10 Much better
13 45 F Data claims manager 5–6 7/10 Better
14 69 F Retired 11–16 6/10 Better
15 55 M Machine driver 5–6 2/10 Better
16 67 F Unpaid carer 7–10 7/10 Same
17 70 F Retired 5–6 6/10 Better
18 67 M Office manager Symptoms resolved prior to interview, following 4 month duration 2/10 Much better
19 46 M Police service staff 5–6 5/10 Better
20 28 M Left skilled labour job due
to sciatica
Symptoms resolved prior to interview, following 5 month duration 1/10 Completely
recovered
Saunders et al. BMC Musculoskeletal Disorders          (2020) 21:469 Page 6 of 15
Fig. 1 Information on referrals, investigations and treatments received by patient interview participants during the trial: Displays information on
investigations, referrals and treatments received by the patients participating in the interviews, along with average waiting times for receipt of
treatments from the time of referral
Table 2 Summary of key themes: Provides a summary of the findings in relation to each of the key themes identified from the data
Theme Findings summary
Acceptability of the ‘fast-track’ care pathway Both patients and clinicians found it acceptable for patients identified as needing spinal specialist
assessment and consideration for more invasive treatments to be seen by those specialists sooner.
Patients were pleased with the speed of their ‘fast-track’ referral; however, some clinicians expressed
concern that patients with short symptom duration may be ‘fast-tracked’ too soon and that their
symptoms could still resolve naturally. All clinicians expressed reluctance to consider invasive
treatment options too early for these ‘acute’ patients.
Perceived benefits of the ‘fast-track’ care
pathway
Patients and clinicians perceived benefits from the ‘fast-track’ pathway in providing early patient
reassurance based on MRI scan findings, particularly in enabling patients to understand the cause of
their pain and assuring them that there was no serious underlying pathology. However, clinician views
were mixed about the potential longer-term clinical benefits of the ‘fast-track’ care pathway.
Waiting times for onward treatment
following being ‘fast-tracked’
Although patient management following ‘fast-track’ was not altered as part of the trial, patients
highlighted the significant difference between the short timeframe for the initial ‘fast-track’ to MRI
scan and spinal specialist opinion and the usual NHS waiting times after onward referral for more
invasive treatments. This led to uncertainty about how long they would be waiting to receive further
treatments, resulting in dissatisfaction. Clinicians similarly felt that not being able to influence the
timing of the receipt of further treatments once patients joined the waiting lists was a limitation of
the ‘fast-track’ pathway.
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scan findings said they had a big disc problem
and they went on to have a caudal epidural
injection. They got that injection a lot quicker
than they would probably for the normal route,
and that helped them massively in the sense that
they’ve got back to work.
However, there was some variation across clinicians in
their views about the timing of the ‘fast-track’ pathway based
on symptom duration. Thirteen clinicians (7 GPs, 6 spinal
physiotherapists) expressed concern that some patients with
short symptom duration (i.e. under 6weeks) may be ‘fast-
tracked’ too soon and that their symptoms could still resolve
naturally without the need for investigation:
Extract 3
GP 7: My cut-off is if things are no better after
six to eight weeks then it’s looking more like a
chronic issue that’s maybe not going to resolve
easily or quickly. So I would say patients are
being fast-tracked for a scan earlier than I would
[normally]. Potentially you may be seeing people
that would have gone on to just resolve in
another two or three weeks.
These views were reflected in examples given by spinal
physiotherapists of patients seen as part of the ‘fast-
track’ pathway. Whilst the spinal physiotherapists felt
that most patients were ‘fast-tracked’ appropriately, they
reported seeing some patients with symptoms of only a
few weeks’ duration, and based on their assessment they
felt that these patients did not need to see a spinal
specialist, particularly if they were beginning to show
signs of improvement:
Extract 4
Spinal physiotherapist 5: If you had a DVD (i.e.
video) that went through everything, then that would
have been just as good as me being there. As long as
they were getting better at that point, I don’t really
feel they needed to be seen by me really, in terms of
a spinal specialist opinion.
In line with the views in Extracts 3 and 4, above, several
clinicians felt that ‘fast-tracking’ may be more beneficial
for patients who have had symptoms beyond a certain
duration, e.g. 6–10 weeks:
Extract 5
Spinal physiotherapist 7: The only place where it
[the ‘fast-track’ pathway] maybe falls down is them
being referred into that service too soon. I saw a lady
who had only had a two-week history of symptoms
and for me, that’s too early to refer into that kind of
service. But the ones that are a little bit later down
the line, then it’s great to be able to assess them and
have all the investigations done relatively rapidly be-
cause then you can make a decision quickly for that
patient. It’s just where the starting point begins, and
making sure the patients don’t come into it too early
… I’d say anyone that’s coming through [for spinal
specialist opinion] with less than two months or even
up to ten weeks’ worth of symptoms, I’d like them to
have longer to settle conservatively beforehand.
However, in contrast, 7 clinicians – all 4 surgeons, 1
spinal physiotherapist and 2 GPs – did see it as accept-
able for patients with severe symptoms even if of short
duration to be ‘fast-tracked’ as early as possible to a
spinal specialist (i.e. even a few weeks since symptom
onset). However, this was primarily for the purpose of
providing patient reassurance rather than to inform
treatment decisions. The concept of reassurance is
discussed in greater detail later under the third theme:
Perceived benefits of the ‘fast-track’ care pathway.
Extract 6
Spinal surgeon 4: I don’t think getting MRIs done
earlier would be a bad idea. Patients like to have
that reassurance. So I think the MRI scan is more of
a tool to address their mental state rather than to
decide treatment from that point of view … I don’t
think it will change my surgical plan or decision
making or time to treat.
Whilst there was variation amongst clinicians as to the
acceptability of the ‘fast-track’ pathway for patients with
short symptom durations, there was greater agreement
across the three clinician groups about the management
of these ‘acute’ patients following ‘fast-track’ for MRI
scan and spinal specialist opinion at the spinal interface
clinics. Clinicians expressed reluctance to consider inva-
sive treatment options too early for these ‘acute’ patients,
particularly until conservative treatment had first been
tried and failed. There was clearly a reticence among cli-
nicians to move away from their usual stepped care
model for sciatica patients with short symptom
durations:
Extract 7
Spinal surgeon 1: Even if I see patients privately, I
tell them to wait for two to three months anyway;
even if they are paying me I will say wait two or
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three months so that is our standard approach,
that's what we follow.
Interviewer: So if a patient did come to you earlier
would you still take that conservative view point of
‘let's see if it settles down by itself’?
Spinal surgeon 1: Yes, we always do that.
There was a concern expressed by the GPs that if spinal
specialists continue to adopt this conservative ‘wait and
see’ approach for some patients, this may result in spinal
surgeons repeating the patient’s original MRI scan:
Extract 8
GP 5: The difficulty is sometimes if the spinal
surgeons see people at too early a stage they will just
want to try conservative management anyway …
and then repeat the scan.
The extent to which the ‘stepped’ care model is strongly
embedded within usual care for patients with short
symptom durations was also reflected in how some pa-
tients understood the treatment options available to
them following ‘fast-track’:
Extract 9
Patient ID 8: They [the spinal physiotherapist] said
‘well this is the course of how we treat sciatica’. You
wouldn’t go for the big drug [an analogy for the most
intensive treatment] as a first option, you would go
for the small one to see if it had any effect. The big
drug would be the last option, because if that doesn’t
work, where do you go from there? (Male, aged 42)
Perceived benefits of the ‘fast track’ care pathway
Both patients and all three clinician groups perceived bene-
fits from the ‘fast-track’ pathway in providing earlier patient
reassurance based on MRI scan findings, particularly in en-
abling patients to understand the cause of their pain and as-
suring them that there was no serious underlying pathology:
Extract 10
Patient ID 6: I was happy when I had the MRI
because I knew what it was [causing the pain]; I
think that’s half the problem, because you worry
about it otherwise. You think ‘oh my god, what’s
going on there?’ But he [the spinal specialist physio-
therapist] showed me the MRI scan and showed me
exactly where the disc bulge was so at least then you
know exactly what was going on … I know what I’m
coping with and I just feel easier now. That’s 90% of
the battle really, that I know that it’s nothing too
sinister. (Female, aged 60)
Extract 11
Spinal physiotherapist 1: With a lot of these patients
it’s the first episodes of these types of problems that
they’ve ever had and they can be quite dramatic. So
there is a huge amount of anxiety … and one of the
benefits of ‘fast-tracking’ them is at least we can
show them, ‘yes, there is something’, because if
they’ve had a scan that confirms the changes …
there’s nothing sinister or nasty going on. So you can
offer a level of reassurance.
Several patients also highlighted that the ‘fast-track’
pathway led to a greater sense of satisfaction with the
care they had received when compared to previous expe-
riences of NHS care. Notably, four patients reported sat-
isfaction with the ‘fast-track’ pathway despite not having
experienced any improvement in their sciatica symptoms
at the point of their interview. All four had a history of
episodic sciatica, and reported satisfaction in feeling that
something active was being done to address their pain,
which to them represented progress compared with pre-
vious care received:
Extract 12
Patient ID 4: I feel like I’ve got further with you this
time than I’ve got with anyone else. In previous years
I’ve been to so many people for help and everyone
seems to close the door on me, basically, that’s how I
feel. This time it just seems like I’m getting some-
where. (Female, aged 49)
There was some variation within the clinician data
about the potential of the ‘fast-track’ pathway to benefit
patient outcomes over time. One spinal surgeon felt that
the main benefits would be on short-term patient out-
comes, e.g. getting patients back to work sooner, and
that there may be less impact in the longer-term:
Extract 13
Spinal surgeon 2: If the question is: a year down the
line will they be better off if they’d been treated
sooner rather than treated later, the answer is
probably no. The long term outcome varies very little
according to the speed at which they’re treated; but
in terms of getting them back to work, the sooner we
treat them, the sooner we will get them back to that
happy situation.
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However, 4 GPs highlighted the potential for longer-
term benefits of ‘fast-tracking’ in terms of intervening
earlier in order to prevent patients from developing a
chronic pain problem and becoming dependent on
medication:
Extract 14
GP 8: I think it’s preventing people from going down
into that chronicity and all the other issues that go
alongside that, with dependency, like Diazepam,
health-seeking … the behaviour around being an
invalid.
Waiting times for onward treatment following ‘fast-track’
The final theme relates to patients’ and clinicians’ views
on waiting times for treatment following assessment at
the spinal interface clinics and onward referral. Although
patient management following ‘fast-track’ was not
altered as part of the trial (i.e. patients referred for
onward treatments joined usual NHS waiting lists),
understanding views on the ‘fast-track’ pathway within
the context of the broader care pathway for patients with
sciatica is an important part of understanding its overall
acceptability.
Patients generally reported feeling satisfied with deci-
sions about onward referrals following assessment at the
spinal interface clinics. However, they highlighted the
significant difference between the short timeframe for
the initial ‘fast-track’ to MRI scan and spinal specialist
opinion (on average 11.5 days between randomisation
and spinal specialist appointment across the 20 patients)
and the usual NHS waiting times after onward referral
for more invasive treatments. For instance, the average
waiting time for the four participants who received an
epidural injection was 49.6 days (i.e. seven weeks) from
the time of referral, and the average waiting time for
patients who were referred straight for an appointment
with a spinal surgeon was 57 days (i.e. 8 weeks). Inter-
view participants who joined these usual NHS waiting
lists reported uncertainty about how long they would be
waiting to receive further treatments, leading to
dissatisfaction:
Extract 15
Interviewer: And how quickly did you go from the
clinic to the MRI?
Patient ID 9: Very quickly, that was a matter of
weeks. But then waiting for the injection they said
would be about a five week waiting list... So five
weeks came, and six weeks came, which kept going
on and on. And I was phoning them and I was still
seeing my own doctor, and he was like “We need to
get something sorted with this.” And I was phoning
and phoning them and an appointment then came
through as a cancellation … So after initially saying,
it’s sort of about a five week wait, it was longer and
it would have been even longer still. (Female, aged
44)
For four patients, the speed of their initial ‘fast-track’
coupled with what they perceived as the thorough nature
of the investigation led them to believe their condition
must be severe in order to warrant such prompt atten-
tion. Thus, having been ‘fast-tracked’ for MRI and spinal
specialist assessment, they expected they would similarly
receive any required further treatment quickly; that is,
despite the patient information about the trial informing
them that this would not be the case. This suggests that
whilst MRI scan findings can provide reassurance, as
highlighted earlier, for some patients being ‘fast-tracked’
had the opposite effect, leading them to believe they had
a particularly serious problem. As a result, joining usual
NHS waiting lists for further treatment led to a degree
of frustration and distress:
Extract 16
Patient ID 13: Because of the speed I went from the
doctor to there [the SCOPiC clinic], to the MRI to
the specialist; I thought ‘yeah there’s got to be some-
thing wrong here’, for them to have spent the 9 hours
and so on, on treatment to get me to this point. And
then for it to stop, you think, ‘well where do I go from
here? Who can I talk to just to get things moving?’
(Female, aged 45)
Following ‘fast-track’ 4 patients received a physiother-
apy referral at the same time as being referred for a
caudal epidural injection (see Fig. 1, earlier). The explan-
ation patients gave about this decision was that due to
the anticipated waiting time for epidural injections, they
had been referred for physiotherapy to see if this might
improve their symptoms whilst they wait for the
injection:
Extract 17
Patient ID 10: The physio said, “Right the next step
is physio and we'll wait for the injection”. We'll do
that while we wait for that one [i.e. the epidural
injection]
Interviewer: So they said have the physio while you're
waiting?
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Patient ID 10: While we're waiting, yeah.
Interviewer: To see if that can help in the meantime?
Patient ID 10: Yes, that’s right. (Male, aged 57)
However, not all patients expressed dissatisfaction with
waiting times for onward treatments. In fact, some pa-
tients had been offered invasive treatments but decided
against these following discussions with the clinician.
These decisions were often informed by patients weigh-
ing up the perceived risks and benefits associated with
different treatment options:
Extract 18
Patient ID 5: I was offered the steroid treatment [i.e.
epidural steroid injection] by the physio. I didn’t
really want to take it on because she said there were
risks involved; because I said at the moment I can
tolerate it, it’s not that bad. If it got to the stage
where it was crippling and I couldn’t get out of bed
and stuff and couldn’t dress myself, I’d have to think
about having something done. That would forfeit the
risk involved then. (Male, aged 44)
Clinicians across all three groups also expressed
concerns about patients having to go onto usual NHS
waiting lists to receive further treatments following ‘fast-
track’. Echoing the views of patients in Extracts 15 and
16 above, four clinicians (2 surgeons, 2 GPs) felt that
‘fast-tracking’ patients for an MRI scan and spinal
specialist consultation could result in patients anticipat-
ing that their sciatica symptoms will be resolved quickly,
leading to unmet expectations if they then have to wait
several weeks or months for further treatments:
Extract 19
Spinal surgeon 3: There’s no point in investigating
these patients quickly if you then have to put them
on a long waiting list before they’re allowed to have
them [i.e. spinal injections]. It’s unfair to get
patients’ expectations up.
It is important to note that, as highlighted earlier in
relation to the first theme, patients would still receive
further treatments sooner overall as result of getting
onto NHS waiting lists sooner; but nevertheless, not
being able to influence the timing of the receipt of
further treatments once they joined the waiting lists was
seen as a limitation of the ‘fast-track’ pathway:
Extract 20
Spinal physiotherapist 4: We can ‘fast-track’ it to a
point but then we can’t then necessarily influence
the speed with which the next step, the next inter-
vention occurs. So if we do deem that person as being
appropriate for having an injection, but then there’s
a long waiting time for injections, that’s out of our
hands. So whilst we can get them to this point [i.e.
MRI scan and spinal specialist opinion] quicker we
can’t then necessarily get them onto the next stage
any quicker.
Discussion
Exploring the identified themes in relation to
normalisation process theory (NPT) and the ‘boundary
object’ concept
The findings presented indicate that all groups perceived
benefit from the ‘fast-track’ care pathway to MRI scan
and spinal specialist consultation in the stratified care
approach tested in the SCOPiC trial; both in relation to
clinical outcomes and in providing reassurance to
patients based on MRI scans. When explored through
the lens of NPT, these findings suggest that the ‘fast-
track’ pathway was able to establish a degree of ‘coher-
ence’ (i.e. made sense) to both patients and clinicians, in
that they appeared to ‘buy in’ to the aims of the ‘fast-
track’ pathway, and saw it as making a meaningful
improvement to current care. Considered in relation to
Allen’s [22] conceptualisation of care pathways as
‘boundary objects’, the ‘fast-track’ pathway can be seen
to have, at least in part, enabled the bringing together of
the different stakeholders’ goals, particularly in relation
to reassuring patients with sciatica early on.
This reassurance related to patients receiving an ex-
planation for the cause of their pain and feeling assured
that there was no serious underlying pathology; what
Pincus et al. [28] classify as ‘cognitive reassurance’. This
finding contrasts with other literature, including argu-
ments by Wheeler et al. [29], that imaging patients with
LBP can lead to distress if aberrant findings are identi-
fied. The reason for the difference in findings may be
that in the case of non-specific LBP, often no obvious
cause of pain is identified through scan results, leading
patients to experience frustration and uncertainty to-
wards unexplained symptoms [30]. Or, as Wheeler et al.
suggest, imaging may show up ‘abnormalities’, which
‘frequently fall within the range of age-related norms’,
but which patients perceive as indicating ‘damage’, caus-
ing them to feel anxious rather than reassured. However,
in the case of sciatica, a clear biomedical cause is more
often present, as was the case with all the patients inter-
viewed in this study who received an MRI scan. This
meant that patients better understood their condition
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and had more certainty surrounding symptoms, leading
to stronger cognitive reassurance. It could be suggested
that understanding the cause of their pain was particu-
larly important for this group of individuals with sciatica,
as part of the reason for many of them having been
stratified to the ‘fast-track’ subgroup was that they
initially experienced acute, severe pain.
It may be that the explanation of the MRI scan results
also contributed to this cognitive reassurance, as was
shown in Extract 10, earlier, in which the patient
highlighted the explanation she was given by the clinician
about the imaging results as contributing to her reassur-
ance. Ong et al. [31] have similarly highlighted the import-
ance patients with sciatica place on receiving clear
information about their diagnosis from clinicians. On the
SCOPiC fast-track pathway, MRI scan results were com-
municated by a spinal specialist clinician (physiotherapist),
who, given their knowledge and experience, are in a pos-
ition to communicate results in a clear and expert man-
ner. This finding could indicate that who (i.e. which
professional) delivers the scan results, and how these are
communicated to the patient can have important effects
on the patient’s level of reassurance.
However, not all patients reported feeling reassured,
and for four patients the speed of receiving the scan and
seeing the spinal specialist led to concerns that their
condition was particularly severe, which in contrast to
the above suggests a lack of coherence of the ‘fast-track’
pathway. This highlights the importance of clinicians
giving a clear explanation to patients about why they are
being referred for investigation and spinal specialist
opinion, so that this does not result in unnecessary
worry on the part of patients.
Despite this, all patients reported being pleased with
the short timeframe for receiving an MRI scan and
spinal specialist consultation, similar to the previous
findings about the importance patients with sciatica
place on early investigation [32]. However, this may
represent a mismatch between the respective goals/
agendas of the patients and clinicians that is
highlighted in the ‘boundary object’ concept. Whilst
patients may perceive waiting times for investigations
from a mind-set of ‘the sooner the better’, some clini-
cians raised concerns about the suitability of patients
with acute symptoms for early investigations, and a
reticence about early MRI scans. For these clinicians,
the ‘fast-track’ pathway appeared less successful in
achieving ‘coherence’, as there was a concern that
‘acute’ patients’ symptoms may well resolve without
the need for imaging and spinal specialist consult-
ation. Some spinal surgeons and GPs did feel it was
acceptable for patients with short symptom duration
to be ‘fast-tracked’, but only to provide early reassur-
ance rather than to direct treatment.
In general, there was a reluctance among clinicians to
consider more invasive treatments following ‘fast-track’
for patients with symptom durations of less than 6
weeks, or even 2–3 months. This appeared to reflect the
overall expectation of a favourable natural course of
most patients with sciatica, as well showing the degree
to which the current ‘stepped’ care approach is strongly
embedded in routine clinical care; clinicians were reti-
cent to move away from this approach. Intervening too
early with these patients therefore represented a lack of
‘coherence’ with usual ways of working. These views
show similarity with findings in other healthcare con-
texts; Hofstede et al. [33] observed in the Dutch context
a reluctance on the part of clinicians to refer patients
with short symptom duration for investigations and
specialist opinion before a period of conservative man-
agement has first been tried, and failed. In the context of
the SCOPiC trial, this meant that for some patients,
having initially been ‘fast-tracked’ they then received
conservative treatments similar to those received by pa-
tients who were not on the fast-track pathway. This was
reflected in Fig. 1, earlier, which shows that 16 of the 20
patients interviewed were referred for physiotherapy as a
first treatment option following their spinal specialist
assessment.
A lack of coherence of the ‘fast-track’ pathway was
also evident in views towards broader organisational/sys-
tem level factors [16], in that both patients and clinicians
highlighted limitations in the ‘fast-track’ pathway in not
being able to influence waiting times for further treat-
ment. Some clinicians did show a recognition that ‘fast-
tracking’ patients through the initial phase of the care
pathway results in them waiting less time overall for
treatments when compared to usual care. However,
clinicians and patients highlighted the incongruence
between the short ‘fast-track’ timeframe for patients re-
ceiving an MRI scan and spinal specialist opinion (on
average 11.5 days), compared with the usual NHS
waiting times for receiving further treatments such as
epidural injections (on average 7 weeks for the four
interview participants who received an epidural injection
during the trial). Particularly for patients, the ‘fast-track’
pathway was seen as less ‘meaningful’ given that ‘fast-
track’ did not extend to the receipt of these further
treatments.
Contribution of findings in providing insights on the ‘fast-
track’ pathway tested in the RCT
Patients in the stratified care arm of the trial showed a
small but not statistically significant difference in time to
first resolution of symptoms (those managed using
stratified care reached resolution 2 weeks earlier than
those in non-stratified care; a median of 10 weeks versus
12 weeks) [10]. Similarly, exploratory, pre-specified
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subgroup analysis showed a small difference of 1 week
(median) in time to resolution of symptoms, in favour of
stratified care for the ‘fast-track’ patient group. The find-
ings presented in this paper can provide useful insights
for understanding the fast-track pathway and the out-
comes of patients on it. Of the 20 patients interviewed,
following spinal specialist consultation 16 were referred
for conservative treatment, and four were referred to a
spinal surgeon (see Fig. 1, earlier). This could be in part
down to the lack of ‘coherence’ clinicians indicated in
considering invasive treatment options for patients
with short symptom duration, and is indicative of the
overall preference of clinicians to allow nature some
time to take its course in sciatica, before more
invasive treatments are used. However, even when in-
vasive treatments were recommended by spinal
specialists, some patients reported instead choosing to
opt for physiotherapy. Therefore, whilst the findings
showed that both patients and clinicians reported
benefits of the ‘fast-track’ pathway, there was collect-
ive clinical reluctance, and reluctance from some pa-
tients, to consider invasive treatments early on. In
this respect, therefore, this facet of the stratified care
model tested in the trial was not consistently helpful
to clinicians in their discussions with their patients
about management options.
Additionally, whilst the aim of the ‘fast-track’ pathway
was only to shorten the timeframe for patients to receive
an MRI scan and spinal specialist consultation – which
was successfully achieved for those patients interviewed
– patients and clinicians felt that ‘fast-track’ did not ex-
tend far enough, they wanted the ‘fast-tracking’ applied
to the whole patient pathway (i.e. from first presentation
in general practice, through to the receipt of invasive
treatments, if required), rather than joining usual NHS
waiting lists for further treatment.
Strengths and limitations
A strength of this study is the parallel investigation of
both patients’ and clinicians’ views, allowing access to a
range of different perspectives about the ‘fast-track’
pathway that was tested in the SCOPiC trial. The total
sample of 40 interview participants was suitably large to
allow for the identification of trends across the dataset,
and the use of the two theoretical frameworks – NPT
and the ‘boundary objects’ concept – enabled us to de-
velop a more robust understanding of the identified is-
sues. The multidisciplinary team involved in data
analysis was a further strength; as well as PPIE input
into the interpretation of the patient data, which in-
creases the trustworthiness of the findings presented.
A potential limitation is that interviews with spinal
surgeons and GPs commonly involved hypothetical dis-
cussions about patients in the ‘fast-track’ pathway, rather
than reflecting on concrete experiences of specific pa-
tients in the SCOPiC trial (any one GP or surgeon only
saw small numbers of patients in the trial spread over a
two-year period, thus hampering recall). This compared
with spinal physiotherapists who were able to draw on
examples of patients they had seen in spinal interface
clinics through the ‘fast-track’ pathway. However, the
adoption of the ‘fast-track’ pathway requires communi-
cation between clinicians across the care pathway and
therefore gaining the views of these different clinician
groups as to the acceptability of this approach holds im-
portant insights.
The study is in some ways particular to the UK NHS
setting, which could limit the applicability of findings to
other healthcare contexts. For instance, whilst physio-
therapists can develop into roles as spinal specialist
clinicians in many healthcare systems other than the UK
─ and therefore this role is not entirely unique to the
UK NHS ─ we acknowledge that this may be unusual
in some countries. Additionally, the issues we have iden-
tified in relation to waiting times following referral to
secondary care services is different in the NHS when
compared to many other countries, particularly those in
which healthcare is accessed through private healthcare
insurance. However, despite these differences between
healthcare systems, several of the findings presented do
have broader applicability across different healthcare
contexts. In particular, views about the role of early im-
aging and spinal specialist opinion in providing reassur-
ance to patients with severe sciatica symptoms, and the
collective clinical reluctance observed towards moving
away from a stepped care approach in managing sciatica
of short duration, with a preference for early conserva-
tive management to allow for the possibility of natural
resolution of symptoms, have relevance to clinical prac-
tice beyond the UK setting.
When interpreting these findings, it is also important to
acknowledge the influence of the researcher’s contribu-
tions on participants’ interview responses. The interviewer
was part of the SCOPiC trial team, and therefore his close
involvement with the trial could have had the potential to
influence the way in which participants’ views were elic-
ited. It was made explicit to participants that the inter-
viewer was part of the trial team; however, it was also
emphasised to participants that we were interested in in-
vestigating both positive and negative aspects of partici-
pants’ experiences, and the variation in views observed
suggests that participants were not led into adopting a
particular stance in line with that of the interviewer.
Conclusion
This paper explored patients’ and clinicians’ perceptions
of a ‘fast-track’ pathway to MRI scan and spinal
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specialist consultation for patients with sciatica consult-
ing in primary care, offered as part of a new stratified
care model tested within the SCOPiC trial. Whilst the
‘fast-track’ pathway was found to achieve a degree of ‘co-
herence’ [16] in that both patients and clinicians per-
ceived added value, particularly in providing early
reassurance, the pathway was less ‘meaningful’ to some
clinicians for managing patients with acute symptoms
(typically less than 6 weeks). This indicated a general re-
luctance on the part of clinicians to intervene too early,
reflecting the expectation of natural resolution in most
cases of sciatica, as well as a reticence to move away
from the current, ‘stepped care’ model. Both patients
and clinicians also felt that the ‘fast-track’ pathway was
limited in that it did not extend to shorten the time pa-
tients waited for further treatments after their spinal
specialist consultation; therefore, whilst the principle of
‘fast-tracking’ patients was seen as acceptable, it was per-
ceived as being limited in scope.
These findings help us to better understand this aspect
of the stratified care intervention tested in the trial.
Based on the RCT findings outlined earlier (see [10] for
further details), there is no strong justification to imple-
ment this model of stratified care for patients with
sciatica, but other models of stratification could be de-
veloped and would require testing. With this in mind,
the qualitative findings presented here have implications
for future intervention design, as well as future manage-
ment of patients with sciatica. Firstly, future research ex-
ploring early referral of patients with sciatica with severe
symptoms for consideration of treatments such as
surgery or spinal epidural injections must account for
and address the difficulties in bringing about clinician
behaviour change, given that the current stepped care
approach was found to be so strongly embedded in
routine practice for the care of patients with short
duration of symptoms. Secondly, findings also indicate
the importance that both clinicians and patients place
on ‘cognitive reassurance’ [28] being given to patients
with severe sciatica symptoms, and the role that imaging
can play in providing this type of reassurance in cases
where imaging reveals a clear explanation for the
patient’s pain, and where this is accompanied by a
thorough explanation from a trusted clinical expert.
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